Vibhor Goyal

Vibhor Goyal

Active Director Designated Partner DIN 03614002
DIN 03614002 First appointment Sep 2011 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 3 historical roles
Total affiliations 7 Since Sep 2011
Shareholding value •••• Premium profile

About Vibhor Goyal

Data last updated:

Vibhor Goyal has 15 years in corporate governance. Holds Designated Partner and Partner roles. Currently with 4 companies, including Smilax Psyllium Impex Llp and Cynamid Pharmachem Llp. Formerly with 3 companies, such as Smilax Healthcare Private Limited and Cynamid Pharmachem Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹175 Cr; the largest is Biogenetic Drugs Private Limited at ₹115 Cr (FY 2025).

DIN 03614002
Primary Designation Designated Partner
First Appointment 06 Sep 2011
Oldest Company Age 22 yrs
Largest company Biogenetic Drugs Private Limited · ₹115 Cr (FY 2025)
Combined revenue ₹175 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biogenetic Drugs Private Limited U24232RJ2004PTC018909
Director21 Jan 20122004₹115 Cr (FY 2025)Active
Designated Partner18 Dec 20182018₹59.31 Cr (FY 2022)Active
Partner07 Jul 20232018–Active
Designated Partner16 Jul 20182018–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Smilax Healthcare Private Limited U24232RJ2005PTC020676
Additional Director15 Mar 20182005₹3.28 Cr (FY 2025)Active
Cynamid Pharmachem Private Limited U24232RJ2011PTC036374
Director06 Sep 20112011–Converted To Llp
Preet International Private Limited U45201DL1997PTC091312
Director25 Dec 20131997₹49.2 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Smilax Psyllium Impex Llp
Cynamid Pharmachem Llp
Duramed Healthcare (India) Llp
Biogenetic Drugs Private Limited
Premium access

Shareholding and investment profile for Vibhor Goyal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vibhor Goyal

Vibhor Goyal has 15 years in corporate governance. Holds Designated Partner and Partner roles. Currently with 4 companies, including Smilax Psyllium Impex Llp and Cynamid Pharmachem Llp. Formerly with 3 companies, such as Smilax Healthcare Private Limited and Cynamid Pharmachem Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹175 Cr; the largest is Biogenetic Drugs Private Limited at ₹115 Cr (FY 2025).

Vibhor Goyal is associated with 4 companies as Designated Partner and Partner, including Biogenetic Drugs Private Limited (₹115 Cr), Smilax Psyllium Impex Llp (₹59.31 Cr), Duramed Healthcare (India) Llp.

Vibhor Goyal has expertise in General Business, Healthcare.

Vibhor Goyal has 15 years in corporate governance.

By reported revenue, the largest current company of Vibhor Goyal is Biogenetic Drugs Private Limited, with revenue of ₹115 Cr (FY 2025).

The 2 current companies of Vibhor Goyal that report revenue have a combined latest revenue of ₹175 Cr.

Vibhor Goyal currently holds positions at 4 companies: Biogenetic Drugs Private Limited (₹115 Cr), Smilax Psyllium Impex Llp (₹59.31 Cr), Duramed Healthcare (India) Llp, Cynamid Pharmachem Llp.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available